| Literature DB >> 35794589 |
Aivars Cīrulis1, Bengt Hansson2, Jessica K Abbott3.
Abstract
Sex chromosomes are typically viewed as having originated from a pair of autosomes, and differentiated as the sex-limited chromosome (e.g. Y) has degenerated by losing most genes through cessation of recombination. While often thought that degenerated sex-limited chromosomes primarily affect traits involved in sex determination and sex cell production, accumulating evidence suggests they also influence traits not sex-limited or directly involved in reproduction. Here, we provide an overview of the effects of sex-limited chromosomes on non-reproductive traits in XY, ZW or UV sex determination systems, and discuss evolutionary processes maintaining variation at sex-limited chromosomes and molecular mechanisms affecting non-reproductive traits.Entities:
Keywords: Gene expression; Heterochromatin; Loss of chromosome Y; Sex differences; UV chromosomes; W chromosome; Y chromosome
Mesh:
Year: 2022 PMID: 35794589 PMCID: PMC9261002 DOI: 10.1186/s12915-022-01357-5
Source DB: PubMed Journal: BMC Biol ISSN: 1741-7007 Impact factor: 7.364
Fig. 1.There are three sex chromosome systems. Two systems exist in diploid organisms—XY (e.g. mammals), where male is the heterogametic sex (A), and ZW (e.g. birds), where female is the heterogametic sex (B). While in haploid organisms there is the UV system (e.g. some mosses), where the female gametophyte is U and the male is V (C)
Affected non-sexual phenotypes by Y chromosome in mammals
| Phenotype | Mechanism of action | Species | References |
|---|---|---|---|
| Aggression | MSY | Human | [ |
| Mainly MSY acting through increased testosterone | Mouse | [ | |
| MSY acting through increased tesosterone and decreased serotonin | Rat | [ | |
| Alcoholism | Y chromosome haplogroups | Human | [ |
| Alzheimer’s disease | LOY | Human | [ |
| Anxiety | Chromosome Y consomic strains (also imprinting the daughter’s genome, thus decreasing anxiety) | Mouse | [ |
| Autism | Extra Y or variation in it ( | Human | [ |
| Mouse | [ | ||
| Chemosensory system | MSY (chromosome Y consomic strains) | Mouse | [ |
| Dopamine system | Human | [ | |
| MSY through tesosterone in hippocampus | Mouse | [ | |
| Chromosome Y consomic strains ( | Rat | [ | |
| Hearing impairment | Human | [ | |
| Intelligence | Reduction due to extra Y, p.I679V NLGN4Y | Human | [ |
| Macrocephaly and brain size | Y chromosome increases size | Human | [ |
| Motor functioning | Larger or extra Y as well as | Human | [ |
| Possibly through | Rat | [ | |
| Norepinephrine concentration | Possibly through | Rat | [ |
| Parkinson’s disease | Human and rat | [ | |
| Response acquisition | Y epistatically interacts with autosome 9 | Mouse | [ |
| Schizophrenia | LOY | Human | [ |
| Stress | Y, possibly through | Rat | [ |
| Suicide | LOY in blood | Human | [ |
| Atherosclerosis | MSY (mainly lower expression of | Human | [ |
| Cardiomyocyte size | Due to different responses to testosterone | Mouse | [ |
| Coronary artery disease | MSY (mainly lower expression of | Human | [ |
| Hypertension | Protective role through increased expression of | Human | [ |
| Y has a protective role | Mouse | [ | |
| Through Sry affecting several renin-angiotensin and SNS gene promoter activity | Rat | [ | |
| Lipid profile | Y haplotypes (possible gene - lnc-KDM5D-4) | Human | [ |
| Chromosome Y consomic strains | Mouse | [ | |
| Chromosome Y consomic strains | Rat | [ | |
| Na and insulin levels | Chromosome Y consomic strains ( | Rat | [ |
| Autoimmunity | LOY in blood | Human | [ |
| Copy number variation of | Mouse | [ | |
| Immune cell abnormalities | Independent of | Mouse | [ |
| Loss of | Human | [ | |
| Viral infections | Haplogroup I | Human | HIV-1 [ |
| Chromosome Y consomic strains (independent of | Mouse | Coxsackievirus B3 [ | |
| Albuminuria | Chromosome Y consomic strains | Rat | [ |
| Cancer | LOY, aneuploidy, misexpression of MSY genes in somatic cells, microdeletions | Human | [ |
| Loss of UTY | Mouse | [ | |
| Rat | [ | ||
| Baldness | SRY in the scalp | Human | [ |
| Body size | MSY increases height independently of sex hormones | Human | [ |
| Y epistatically interacts with autosome 9 independently of | Mouse | [ | |
| Diabetes | LOY | Human | [ |
| Glucose metabolism | Y interacts with chromosome 2 | Rat | [ |
| Hirschsprung disease | SRY represses RET | Human | [ |
| Hypertelorism | Extra Y | Human | [ |
| Liver damage | LOY | Human | [ |
| Macular degeneration | LOY in blood | Human | [ |
| Mortality | Extra Y and LOY in blood decreases lifespan, while hypermethylation of Y has a protective mechanism | Human and other mammals | [ |
| Sensitivity to testosterone | MSY | Mouse | [ |
| Tooth growth | Genes on the Yqll promote | Human | [ |
Fig. 2.Gene loss and specialization over time on NRSCs. The rate of gene loss is expected to decrease with time since recombination cessation, as non-essential genes are lost early in this process, while essential genes can be maintained through purifying selection. In contrast, the rate of specialization may be more or less constant since it will likely be dependent on mutation accumulation
Fig. 3.NRSC (in grey) mechanisms of action (Table 1). Direct mechanisms include (1) protein-coding gene expression in somatic tissues, while indirect mechanisms are exerted through (2) regulation of other chromosomes (via transcription factors, non-coding RNAs, heterochromatin effects or imprinting) or (3) sex hormones